{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T15:09:02Z","timestamp":1724684942121},"reference-count":49,"publisher":"Baishideng Publishing Group Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJH"],"published-print":{"date-parts":[[2022,4,27]]},"DOI":"10.4254\/wjh.v14.i4.827","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T06:25:12Z","timestamp":1650608712000},"page":"827-845","source":"Crossref","is-referenced-by-count":1,"title":["Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis"],"prefix":"10.4254","volume":"14","author":[{"given":"Rasmus Hvidbjerg","family":"Gantzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikkel Breinholt","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Jepsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels Kristian","family":"Aagaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise Lotte","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Gr\u00f8nb\u00e6k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.09.014"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080532"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra035021"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.024"},{"key":"B5","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Ayuso RM, Arroyo V, Planas R, Gaya J, Bory F, Rimola A, Rivera F, Rod\u00e9s J. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. Gastroenterology 1983; 84: 961-968","DOI":"10.1016\/0016-5085(83)90198-1"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1993.tb00624.x"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807303390507"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/BF01726570"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1994.tb16194.x"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1992.262.3.R395"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840160109"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3109\/00365519509104964"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90156-r"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000167983"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1989.tb00418.x"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220620"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"B18","unstructured":"Higgens JPT, Thomas J, Chandler J, Cumpston M, Li T, Welch VA.   Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). [cited 20 June 2021]. Available from: https:\/\/training.cochrane.org\/handbook"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"B20","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P.   The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [cited 20 June 2021]. Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91811-h"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/BF01647578"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)90777-4"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1139\/y93-022"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/BF02779451"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080106"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-6386(12)80392-1"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90027-a"},{"key":"B30","doi-asserted-by":"crossref","unstructured":"Wong F, Tobe S, Legault L, Logan AG, Skorecki K, Blendis LM. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation. Hepatology 1993; 18: 519-528","DOI":"10.1002\/hep.1840180308"},{"key":"B31","doi-asserted-by":"crossref","unstructured":"Abraham WT, Lauwaars ME, Kim JK, Pe\u00f1a RL, Schrier RW. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis. Hepatology 1995; 22: 737-743","DOI":"10.1002\/hep.1840220308"},{"key":"B32","unstructured":"Ando M. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration]. Nihon Jinzo Gakkai Shi 1991; 33: 791-801"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150513"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-199001000-00002"},{"key":"B35","unstructured":"Gerbes AL, Arendt R, Xie Y, Knorr HJ, Riedel A, Paumgartner G. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver]. Z Kardiol 1988; 77 Suppl 2: 99-103"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V981489"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-7-1"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(81)90370-2"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-68964-5_15"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(85)92617-0"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112368"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/endo-115-5-2026"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/science.3006248"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/science.6857267"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198603273141306"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197006182822502"},{"key":"B47","unstructured":"Gantzel RH, Meyer M, Mazgareanu S, Aagaard NK, Jepsen P, Holzmeister J, Watson H, Gr\u00f8nb\u00e6k H. Ularitide as treatment of refractory ascites in cirrhosis- a study protocol for a randomised trial. Dan Med J 2021; 68"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl337"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-3-653"}],"container-title":["World Journal of Hepatology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v14\/i4\/827.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T06:26:53Z","timestamp":1650608813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v14\/i4\/827.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":49,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.4254\/wjh.v14.i4.827","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,27]]}}}